Ischemia-modified albumin predicts mortality in ESRD.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Kidney Diseases

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/J.AJKD.2005.11.026PMID 16490629
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of the Albumin cobalt Binding (ACBTM) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction

  2007cited by this paper
• Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T.

  2004cited by this paper
• Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients.

  2004cited by this paper
• Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.

  2004cited by this paper
• Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia.

  2004cited by this paper
• Ischemia Modified Albumin Is a Sensitive Marker of Myocardial Ischemia After Percutaneous Coronary Intervention

  2003cited by this paper
• Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice

  2003cited by this paper
• Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value.

  2003cited by this paper
• Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction.

  2003cited by this paper
• Ischemia-modified Albumin (IMA) Is Useful in Risk Stratification of Emergency Department Chest Pain Patients

  2003cited by this paper
• Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.

  2003cited by this paper
• The search for a biomarker of cardiac ischemia.

  2003cited by this paper
• An Assessment of the Prognostic Value of Exercise Treadmill Testing Utilizing the Duke Score in Risk Stratification of Emergency Department Chest Pain Unit Patients

  2003cited by this paper
• Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race.

  2002cited by this paper
• Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease

  2002cited by this paper
• Increased Circulating Levels of Natriuretic Peptides Predict Future Cardiac Event in Patients with Chronic Hemodialysis

  2002cited by this paper
• The Prognostic Role of Brain Natriuretic Peptides in Hemodialysis Patients

  2002cited by this paper
• Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

  2001cited by this paper
• Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study.

  2001cited by this paper
• Cardiac Troponin T Predicts Mortality in Patients With End-Stage Renal Disease

  2000cited by this paper
• Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures: A Comparative Simultaneous Doppler-Catheterization Study

  2000cited by this paper
• C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients.

  2000cited by this paper
• Use of recombinant human cardiac Troponin T for standardization of third generation Troponin T methods.

  1999cited by this paper
• Causes of death. United States Renal Data System.

  1998cited by this paper
• Pre-operative echocardiographic abnormalities and adverse outcome following renal transplantation.

  1998cited by this paper
• Outcome and risk factors for left ventricular disorders in chronic uraemia.

  1996cited by this paper
• The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients.

  1993cited by this paper
• Stress echocardiography for detection of coronary artery disease.

  1991cited by this paper
• Uremic cardiomyopathy: an inadequate left ventricular hypertrophy.

  1987cited by this paper
• Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method

  1977cited by this paper

• Obesity-Related Glomerulosclerosis—How Adiposity Damages the Kidneys

  2025cites this paper
• Evaluation of Oxidative Stress and Trace Elements in Term and Late-Term Pregnancies

  2024cites this paper
• A Study of Oxidative Stress, Inflammation, and Endothelial Dysfunction in Diabetic and Nondiabetic Chronic Kidney Disease Pre-Dialysis Patients

  2023cites this paper
• Independent correlation between ischemia modified albumin and parathormone in hemodialysis patients

  2023cites this paper
• The effects of the renin–angiotensin–aldosterone system blockers on serum ischemia-modified albumin levels in autosomal dominant polycystic kidney disease

  2022cites this paper
• Diagnostic Accuracy of Ischemia-Modified Albumin for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis

  2022cites this paper
• Evaluation of cardiovascular risk in children with solitary functioning kidney

  2022cites this paper
• Biomarkers and Predictors of Adverse Cardiovascular Events in Different Stages of Chronic Kidney Disease

  2022cites this paper
• Biomarkers of Uremic Cardiotoxicity

  2021influential citation
• Levels of Ischemia: Modified Albumin in Patients Undergoing On-pump Coronary Artery Bypass.

  2020cites this paper
• Is ischemia modified albumin a good marker in acute exacerbation of chronic obstructive pulmonary disease?

  2020cites this paper
• The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients.

  2020cites this paper
• Effects of medium cut-off dialysis membranes on inflammation and oxidative stress in patients on maintenance hemodialysis

  2020cites this paper
• Prognostic Value of Cardiac Troponin in Patients With Chronic Kidney Disease Without Suspected Acute Coronary Syndrome

  2020cites this paper
• Oxidative stress is important in the pathogenesis of stress-related mucosal disease

  2020cites this paper
• Ischemia-Modified Albumin Is Associated with Arterial Stiffness in Hemodialysis Patients.

  2020cites this paper
• Ischemia-Modified Albumin, a Novel Predictive Marker of In-Hospital Mortality in Acute Aortic Dissection Patients

  2019cites this paper
• Cardiac risk assessment for end-stage renal disease patients on the renal transplant waiting list

  2019cites this paper
• Biomarkers of Cardiac Ischemia

  2019influential citation
• Is ischemia-modified albumin a reliable tool for the assessment of acute pancreatitis?

  2018cites this paper
• A STUDY ON EVALUATION OF ISCHAEMIA MODIFIED ALBUMIN AND ITS RELATIONSHIP IN HYPERTHYROIDISM

  2017cites this paper
• Ischemic Modified Albumin (IMA) as a Novel Marker for Ischemic Heart Disease and Surrogate Marker for Other High Oxidative -Ischemic Conditions

  2017cites this paper
• Ischemia‐modified albumin is a predictor of short‐term mortality in patients with severe sepsis**

  2017cites this paper
• Structural and functional integrity of human serum albumin: Analytical approaches and clinical relevance in patients with liver cirrhosis.

  2017cites this paper
• Prognostic significance of ischemia-modified albumin for severe acute pancreatitis.

  2017cites this paper
• Ischemia-modified albumin in migraine patients during interictal period

  2016cites this paper
• Ischemia Modified Albumin as a Marker of Oxidative Stress in Normal Pregnancy.

  2016cites this paper
• Sudden cardiac death and chronic kidney disease: From pathophysiology to treatment strategies.

  2016cites this paper
• Role of ischemia-modified albumin in clinical practice

  2015cites this paper
• Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels

  2015cites this paper
• Maternal serum ischemia modified albumin as a marker for hypertensive disorders of pregnancy: a pilot study.

  2015cites this paper
• Ischaemia‐modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis

  2015cites this paper
• American College of Cardiology Foundation Candidates: A Scientific Statement From the American Heart Association and the Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation

  2014cites this paper
• Prognostic Value of Cardiac Troponin in Patients With Chronic Kidney Disease Without Suspected Acute Coronary Syndrome

  2014cites this paper
• Correlation of Ischemia-Modified Albumin with SOFA and APACHE II Scores in Preoperative Patients with Colorectal Cancer

  2014cites this paper
• Serum Ischemia-Modified Albumin Levels in Children With Epileptic Seizures

  2014cites this paper
• Smoking is not Associated with Increased Ischemia- Modified Albumin Levels in Acute Coronary Syndrome Akut Koroner Sendromda Sigara İçimi, Artmiş İskemi- Modifiye Albumin Düzeyleri ile İlişkisizdir

  2014cites this paper
• EVALUATION OF ISCHEMIA MODIFIED ALBUMIN AND NITRIC OXIDE LEVELS AND THEIR INTER-RELATIONSHIP IN HYPERTHYROIDISM

  2014cites this paper
• Comparative study of ischemia modified albumin and nitric oxide in hyperthyroidism

  2014cites this paper
• Provisional chapter Biomarkers of Cardiac Ischemia

  2013influential citation
• Ischemia-Modified Albumin as a Marker of Myocardium and Skeletal Muscle Damage

  2013cites this paper
• Ischemia-modified albumin, a predictive marker of major adverse cardiovascular events in continuous ambulatory peritoneal dialysis patients.

  2013cites this paper
• Assessment of serum cobalt binding with diseases of domestic cats

  2013cites this paper
• Patient selection and preoperative evaluation for transplant surgery.

  2013cites this paper
• Ischemia modified albumin and carbonyl protein as potential biomarkers of protein oxidation in hemodialysis.

  2012cites this paper
• EVALUATION OF ISCHEMIA MODIFIED ALBUMIN IN HEPATITIS C POSITIVE HEMODIALYSIS PATIENTS: A PILOT STUDY

  2012cites this paper
• Human albumin in the management of complications of liver cirrhosis

  2012cites this paper
• AHA / ACCF Scientific Statement Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates

  2012cites this paper
• Prevention of sudden cardiac death in patients with chronic kidney disease

  2012influential citation
• Using repeated measures of blood biomarkers and physical biomeasures to define changes in volume status in patients with decompensated heart failure, normal volunteers and patients with stable left ventricular systolic dysfunction

  2012cites this paper
• Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates

  2012cites this paper
• Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates

  2012cites this paper
• The Relationship between Oxidative Stress, Inflammation, and Atherosclerosis in Renal Transplant and End-Stage Renal Disease Patients

  2012influential citation
• Troponin I Levels and Postoperative Myocardial Infarction following Renal Transplantation

  2012cites this paper
• Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and

  2012cites this paper
• Paraoxonase 1 in Chronic Kidney Failure

  2012cites this paper
• Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation

  2012cites this paper
• Ischemia-modified albumin and total antioxidant status in patients with slow coronary flow: a pilot observational study Yavaş koroner akimin görüldüğü hastalarda iskeminin değişikliğe uğrattiği albümin ve total antioksidan durum: Gözlemsel bir pilot çalişma Original Investigation Özgün Araşt›rma

  2011cites this paper
• Influence of ezetimibe monotherapy on ischemia-modified albumin levels in hypercholesterolemic patients

  2011cites this paper
• The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease

  2011cites this paper
• Sudden cardiac death in chronic kidney disease: epidemiology and prevention

  2011cites this paper
• High cut-off dialysis membranes: current uses and future potential.

  2011cites this paper
• Correlation between Ischaemia-Modified Albumin and Intermediate-Density Lipoprotein in Haemodialysis Patients with End-Stage Renal Disease

  2011cites this paper
• Ischemia-modified albumin and total antioxidant status in patients with slow coronary flow: a pilot observational study.

  2011cites this paper
• Paraoxonase-1 and ischemia-modified albumin in patients with end-stage renal disease

  2011cites this paper
• Ischaemia modified albumin: Does it bolster our diagnostic ammunition?

  2011cites this paper
• Differences in ischemia-modified albumin levels between end stage renal disease patients and the normal population.

  2010cites this paper
• Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies.

  2010cites this paper
• Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers.

  2010cites this paper
• Ischemia‐Modified albumin levels in patients with end‐stage renal disease patients on hemodialysis: does albumin analysis method affect albumin‐adjusted Ischemia‐Modified albumin levels?

  2010cites this paper
• Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)

  2009cites this paper
• Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014

  2009cites this paper
• A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin

  2009cites this paper
• Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia.

  2009cites this paper
• Evaluation of ischemia‐modified albumin in anemia associated to chronic kidney disease

  2008cites this paper
• Ischemia-modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain

  2008cites this paper
• Effect of hemodialysis on traditional and innovative cardiac markers

  2008cites this paper
• Prognostic value of ischaemia-modified albumin in patients with non-ST-segment elevation acute coronary syndromes.

  2008cites this paper
• Ischaemia-modified albumin: clinical utility and pitfalls in measurement

  2008cites this paper
• Ischemia Modified Albumin in Normal Pregnancy and Preeclampsia

  2008cites this paper
• AVALIAÇÃO DA ALBUMINA MODIFICADA PELA ISQUEMIA NA ANEMIA ASSOCIADA À DOENÇA RENAL CRÔNICA

  2007cites this paper
• Slow Intravenous Iron Administration Does Not Aggravate Oxidative Stress and Inflammatory Biomarkers during Hemodialysis: A Comparative Study between Iron Sucrose and Iron Dextran

  2007cites this paper
• Evaluation of ischaemia-modified albumin as a marker of myocardial ischaemia in end-stage renal disease.

  2007cites this paper
• The detection of myocardial ischemia in end-stage renal disease.

  2007cites this paper
• AVALIAÇÃO DA ALBUMINA MODIFICADA PELA ISQUEMIA NAANEMIA ASSOCIADA À DOENÇA RENAL CRÔNICA

  2007cites this paper
• Evaluation of the albumin cobalt binding (ACB®) assay for measurement of ischaemia-modified albumin (IMA®) on the Beckman Coulter LX-20

  2006cites this paper
• Evaluation of the albumin cobalt binding (ACBR ) assay for measurement of ischaemia-modified albumin (IMAR ) on the

  2006cites this paper
• UNIVERSIDADE FEDERAL DE SANTA MARIA CENTRO DE CIÊNCIAS DA SAÚDE PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS FARMACÊUTICAS

  2006cites this paper
• Dados Internacionais de Catalogação na Publicação (CIP)

  2005cites this paper